Alleviant Medical Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
44
- Latest Deal Type
-
Series 2
- Latest Deal Amount
-
$90.8M
- Investors
-
17
Alleviant Medical General Information
Description
Developer of medical devices designed to offer treatment for congestive heart failure. The company's devices relieve pressure buildup in the left atrium of the heart that can lead to organ failures and is developing next-generation therapies for heart failure, enabling hospitals to provide symptomatic relief and appropriate treatments to patients.
Contact Information
Website
www.alleviantmedical.comCorporate Office
- 7801 North Lamar Boulevard
- Suite D103
- Austin, TX 78752
- United States
Corporate Office
- 7801 North Lamar Boulevard
- Suite D103
- Austin, TX 78752
- United States
Alleviant Medical Timeline
Alleviant Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC (Series 2) | 19-Dec-2024 | $90.8M | Completed | Clinical Trials - Phase 1 | ||
| 13. Later Stage VC (Series 1) | 23-Jan-2023 | Completed | Clinical Trials - Phase 1 | |||
| 12. Grant | 01-Jan-2022 | Completed | Clinical Trials - General | |||
| 11. Early Stage VC (Series B) | 05-Nov-2020 | Completed | Clinical Trials - General | |||
| 10. Early Stage VC (Series A) | 01-Apr-2019 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 01-Sep-2018 | Completed | Pre-Clinical Trials | |||
| 8. Early Stage VC (Series A) | 30-Mar-2018 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Jan-2018 | Completed | Product In Beta Test | |||
| 6. Seed Round | 18-Dec-2017 | $1.1M | $1.1M | Completed | Product In Beta Test | |
| 5. Accelerator/Incubator | 26-Sep-2017 | Completed | Product In Beta Test |
Alleviant Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 2 | ||||||||
| Series 1 | ||||||||
| Series B-1 | ||||||||
| Series A-2 | 1,741,341 | $0.000010 | $0.06 | $0.75 | $0.75 | 1x | $0.75 | 0.86% |
| Series A-1 | 5,336,671 | $0.000010 | $0.12 | $1.52 | $1.52 | 1x | $1.52 | 2.63% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Alleviant Medical Comparisons
Industry
Financing
Details
Alleviant Medical Competitors (5)
One of Alleviant Medical’s 5 competitors is Cardiac Dimensions, a Venture Capital-Backed company based in Kirkland, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cardiac Dimensions | Venture Capital-Backed | Kirkland, WA | ||||
| V-Wave | Formerly VC-backed | Caesarea, Israel | ||||
| Procyrion | Venture Capital-Backed | Houston, TX | ||||
| WhiteSwell | Venture Capital-Backed | Galway, Ireland | ||||
| Corvia Medical (Therapeutic Devices) | Venture Capital-Backed | Tewksbury, MA |
Alleviant Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Alleviant Medical Patents
Alleviant Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220211380-A1 | Systems, devices, and methods for diagnosing amyloidosis | Pending | 07-Jan-2021 | ||
| EP-4027926-B1 | Systems for forming an anastomosis | Active | 13-Sep-2019 | ||
| EP-4027926-C0 | Systems for forming an anastomosis | Active | 13-Sep-2019 | ||
| ES-3031794-T3 | Systems for forming an anastomosis | Active | 13-Sep-2019 | ||
| JP-2025131654-A | Systems, devices and methods for forming anastomosis | Pending | 13-Sep-2019 | A61B18/1492 |
Alleviant Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Alleviant Medical Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gilde Healthcare | PE/Buyout | Minority | ||
| Long View Ventures | Venture Capital | Minority | ||
| Omega Funds | Venture Capital | Minority | ||
| Gilmartin Capital | Venture Capital | Minority | ||
| Long View Equity Partners | Asset Manager | Minority |
Alleviant Medical FAQs
-
When was Alleviant Medical founded?
Alleviant Medical was founded in 2017.
-
Where is Alleviant Medical headquartered?
Alleviant Medical is headquartered in Austin, TX.
-
What is the size of Alleviant Medical?
Alleviant Medical has 44 total employees.
-
What industry is Alleviant Medical in?
Alleviant Medical’s primary industry is Therapeutic Devices.
-
Is Alleviant Medical a private or public company?
Alleviant Medical is a Private company.
-
What is the current valuation of Alleviant Medical?
The current valuation of Alleviant Medical is .
-
What is Alleviant Medical’s current revenue?
The current revenue for Alleviant Medical is .
-
How much funding has Alleviant Medical raised over time?
Alleviant Medical has raised $189M.
-
Who are Alleviant Medical’s investors?
Gilde Healthcare, Long View Ventures, Omega Funds, Gilmartin Capital, and Long View Equity Partners are 5 of 17 investors who have invested in Alleviant Medical.
-
Who are Alleviant Medical’s competitors?
Cardiac Dimensions, V-Wave, Procyrion, WhiteSwell, and Corvia Medical (Therapeutic Devices) are competitors of Alleviant Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
